ITGSS Certified Technical Associate: Emerging Tech Practice Test

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ITGSS Certified Technical Associate exam with engaging flashcards and detailed multiple-choice questions. Each question includes helpful hints and comprehensive explanations to ensure a deep understanding of emerging technologies. Ace your exam with confidence!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What test is used to evaluate the effects of heparin, aspirin, and antihistamines on the blood clotting process?

Coumadin
PTT
AFP
PSA

The correct answer is: PTT

The test used to evaluate the effects of heparin, aspirin, and antihistamines on the blood clotting process is the PTT, or Partial Thromboplastin Time. This test measures the time it takes for blood to clot and is particularly sensitive to the pathways affected by heparin. Heparin is an anticoagulant that interferes with blood clotting, and monitoring its effect is vital in clinical settings. The PTT is specifically useful for assessing the intrinsic pathway of coagulation, which is impacted by conditions such as the administration of certain anticoagulants. Aspirin, though primarily an antiplatelet agent, can also have effects on coagulation pathways, and tracking its influence through the PTT can provide insights into the overall bleeding risk in patients. Antihistamines generally do not directly influence coagulation, but understanding their overall effects in patients who may be on anticoagulation therapy could offer a comprehensive view when considering patient management. The other options do not pertain to the evaluation of blood coagulation in the context of these substances. Coumadin (a brand name for warfarin) is monitored through different tests, while AFP and PSA are tumor markers used for cancer diagnostics, not for assessing coag